Investigators
This study combines the expertise of Rheumatologist Jill P. Buyon, MD, from NYU School of Medicine and Fetal Cardiologist Bettina F. Cuneo, MD, from University of Arizona College of Medicine
Jill P. Buyon, MD
Director of the Division of Rheumatology, Department of Medicine | Sir Deryck and Lady Va Maughan Professor of Rheumatology
NYU Robert Grossman School of Medicine
NYU Langone Health
Bettina F. Cuneo, MD
Clinical Scholar and Professor of Surgery Adjunct Professor of Pediatrics
University of Arizona College of Medicine
Tucson, AZ
Publications
ABSTRACTS
2021
1. Ambulatory fetal heart rate monitoring to surveil for fetal atrioventricular block in anti-Ro/SSA positive pregnancies. Scientific sessions of the American Heart Association.
2. Ambulatory Fetal Heart Rate Monitoring (FHRM) to Surveil Pregnancies at Risk for Congenital Heart Block. Scientific sessions of the American College of Rheumatology.
3. The STOP BLOQS clinical trial: Fetal heart rate monitoring as an adjunct to echocardiographic surveillance of anti-Ro/SSA positive pregnancies. Scientific sessions of the International Society of Ultrasound in Obstetrics and Gynecology.
2022
4. Contribution of Antibody Titers/Specificities to Adverse Pregnancy Outcomes in a Multicenter Prospective Study of anti-Ro Positive Mothers. Scientific sessions of the American College of Rheumatology.
5. STOP BLOQ: Results of the first 212 pregnancies. Scientific sessions, American Society of Echocardiography.
6. Identification, treatment, and reversal of 2° Av block in an anti-Ro/SSA antibody exposed pregnancy. Scientific sessions, American Society of Echocardiography.
7. We STOPped BLOQ! Scientific sessions, American Society of Echocardiography.
8.Outcome of the first 214 STOP BLOQ pregnancies. International Fetal Medicine and Surgery Society.
2023
9. High anti-Ro/SSA titers are persistent and necessary, but not sufficient to predict fetal AV block. Scientific sessions of the American Heart Association
10. Prospective evaluation of anti-Ro positive pregnancies supports utility of ambulatory fetal heart rate monitoring to detect fetal AV block. Scientific sessions of the American Heart Association.
11. Prospective Evaluation of Anti-SSA/Ro Pregnancies Supports the Utility of High Titer Antibodies and Fetal Home Monitoring for the Detection of Fetal Atrioventricular Block. Scientific sessions of the American College of Rheumatology.
MANUSCRIPTS
1. Buyon JP et.al. Prospective Evaluation of Anti-SSA/Ro Pregnancies Supports High Titer Antibodies and Utility of Fetal Home Monitoring in the Detection of Atrioventricular Block. In press, Nov 2023. Arthritis and Rheumatology
2. Howley LW, et. al. Variation in prenatal surveillance and management of anti-Ro/SSA antibody positive pregnancies. In review, Nov 2023.